Buy or sell Evolve Biosystems stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Evolve Biosystems Stock

Evolve BioSystems is developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.

Founded

2011

Notable Investors

Bill & Melinda Gates Foundation

Headquarters

Davis CA, US

Total Funding

$69.0M

About Evolve Biosystems Stock

Evolve Biosystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. The company builds on more than a decade of research into the infant biome and its intimate interaction with breast milk components established by the founding scientists including Bruce German, David Mills, Carlito Lebrilla, Daniela Barile and Samara Freeman. Their fundamental research and translational clinical trials have been enabled by more than $15 million in federal and private grants since 2004.

Investors

Funding History

August 2015$9.0M
May 2017$20.0M
June 2018$40.0M

Management

Director, IP & Regulatory Affairs

Samara Freeman

Co-Founder

Carlito Lebrilla

CEO

David Kyle

Co-Founder

Bruce German

Co-Founder

David Mills

Co-Founder

Daniela Barile

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Evolve Biosystems or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo